JP2001503020A5 - - Google Patents

Download PDF

Info

Publication number
JP2001503020A5
JP2001503020A5 JP1998507220A JP50722098A JP2001503020A5 JP 2001503020 A5 JP2001503020 A5 JP 2001503020A5 JP 1998507220 A JP1998507220 A JP 1998507220A JP 50722098 A JP50722098 A JP 50722098A JP 2001503020 A5 JP2001503020 A5 JP 2001503020A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998507220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001503020A (ja
Filing date
Publication date
Priority claimed from US08/685,589 external-priority patent/US5916872A/en
Application filed filed Critical
Publication of JP2001503020A publication Critical patent/JP2001503020A/ja
Publication of JP2001503020A5 publication Critical patent/JP2001503020A5/ja
Ceased legal-status Critical Current

Links

JP10507220A 1996-07-24 1997-07-23 広域抗菌活性を有する環状ペプチド Ceased JP2001503020A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/685,589 1996-07-24
US08/685,589 US5916872A (en) 1996-07-24 1996-07-24 Cyclic peptides having broad spectrum antimicrobial activity
PCT/US1997/012974 WO1998003192A1 (en) 1996-07-24 1997-07-23 Cyclic peptides having broad spectrum antimicrobial activity

Publications (2)

Publication Number Publication Date
JP2001503020A JP2001503020A (ja) 2001-03-06
JP2001503020A5 true JP2001503020A5 (enExample) 2005-03-10

Family

ID=24752864

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10507220A Ceased JP2001503020A (ja) 1996-07-24 1997-07-23 広域抗菌活性を有する環状ペプチド

Country Status (8)

Country Link
US (1) US5916872A (enExample)
EP (1) EP0956029B1 (enExample)
JP (1) JP2001503020A (enExample)
AT (1) ATE286740T1 (enExample)
AU (1) AU720100B2 (enExample)
CA (1) CA2261797A1 (enExample)
DE (1) DE69732250D1 (enExample)
WO (1) WO1998003192A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495518B1 (en) 1994-06-13 2002-12-17 Vanderbilt University Method for importing biologically active molecules into cells
US7553929B2 (en) * 1994-06-13 2009-06-30 Vanderbilt University Cell permeable peptides for inhibition of inflammatory reactions and methods of use
US6307016B1 (en) 1995-07-06 2001-10-23 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
USRE38828E1 (en) * 1995-07-06 2005-10-11 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
US6043220A (en) * 1997-12-03 2000-03-28 Intrabiotics Pharmaceuticals, Inc. Threonine-containing protegrins
JP4394279B2 (ja) 1998-03-09 2010-01-06 ジーランド ファーマ アクティーゼルスカブ 酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体
WO2000053621A2 (en) * 1999-03-09 2000-09-14 Jeffrey Lynn Haddox Synthetic complementary peptides and ophthalmologic uses thereof
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
US6337317B1 (en) * 2000-06-27 2002-01-08 The University Of British Columbia Antimicrobial peptides and methods of use thereof
ES2527339T3 (es) * 2001-02-23 2015-01-23 Polyphor Ltd. Peptidomiméticos fijados a patrón con actividad antimicrobiana
US7314858B2 (en) 2001-04-18 2008-01-01 The Regents Of The University Of California Retrocyclins: antiviral and antimicrobial peptides
US6713078B2 (en) 2001-04-18 2004-03-30 The Regents Of The University Of California Retrocyclins: antiviral and antimicrobial peptides
US7119070B2 (en) * 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
WO2003102538A2 (en) * 2002-05-30 2003-12-11 European Molecular Biology Laboratory Combinatorial chemical library ii
AU2003273578A1 (en) * 2002-05-30 2003-12-19 European Molecular Biology Laboratory Combinatorial chemical library i
US8518694B2 (en) 2002-06-13 2013-08-27 Novartis Vaccines And Diagnostics, Inc. Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV
CA2496215C (en) 2002-08-20 2013-07-16 Universitaet Zuerich Template-fixed peptidomimetics with antibacterial activity
WO2004067032A2 (en) * 2003-01-24 2004-08-12 University Of Massachusetts Medical Center Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes
US8067535B2 (en) 2003-01-24 2011-11-29 The University Of Massachusetts Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes
AU2004222306A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
WO2006039163A2 (en) 2004-09-29 2006-04-13 Amr Technology, Inc. Cyclosporin alkyne analogues and their pharmaceutical uses
JP2008514702A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド 新規シクロスポリン類似体およびそれらの薬学的使用
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US20080255052A1 (en) * 2004-12-23 2008-10-16 The Regents Of The University Of California Immunologic regulation by theta defensins
CA2610791C (en) * 2005-06-08 2015-12-01 Cangene Corporation Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
RU2507213C2 (ru) * 2005-10-04 2014-02-20 Солидженикс, Инк., Новые пептиды для лечения и профилактики иммунопатологических заболеваний, включая лечение и профилактику инфекции посредством модулирования врожденного иммунитета
AU2012203804B2 (en) * 2005-12-22 2014-10-16 Novabiotics Limited Cyclic antimicrobial peptides
EP2357190A3 (en) 2005-12-22 2011-08-24 Novabiotics Limited Cyclic antimicrobial peptides
US9181303B2 (en) * 2005-12-22 2015-11-10 Novabiotics Limited Treatment of bacterial infections with cyclic antimicrobial peptides
WO2007079597A1 (en) 2006-01-16 2007-07-19 Polyphor Ltd. Template - fixed peptidomimetics with antimicrobial activity
SG175573A1 (en) * 2006-10-04 2011-11-28 Inimex Pharmaceuticals Inc Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
FR2943345B1 (fr) * 2009-03-19 2011-05-27 Univ Paris Curie Analogues de la temporine-sha et leurs utilisations
EP2853538A1 (en) 2013-09-27 2015-04-01 Université Pierre et Marie Curie (Paris 6) Analogues of temporin-SHa and uses thereof
WO2020264389A1 (en) * 2019-06-26 2020-12-30 Selsted Michael E Novel theta defensin analogs
JP2023117892A (ja) * 2022-02-14 2023-08-24 公益財団法人 鷹揚郷 ヘプシジン結合ペプチド

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4705777A (en) * 1985-02-25 1987-11-10 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5087569A (en) * 1986-11-26 1992-02-11 Cornell Research Foundation, Inc. And The Rockefeller University Antimicrobial proteins, compositions containing same and uses thereof
US5126257A (en) * 1986-11-26 1992-06-30 Cornell Research Foundation Antimicrobial proteins, compositions containing same and uses thereof
US5338724A (en) * 1986-11-26 1994-08-16 Cornell Research Foundation, Inc. Antimicrobial proteins, compositions containing same and uses thereof
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
US5308834A (en) * 1989-02-14 1994-05-03 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
US5334584A (en) * 1989-02-14 1994-08-02 Incyte Pharamaceuticals, Inc. Recombinant, non-glycosylated bpi protein and uses thereof
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5708154A (en) * 1989-02-24 1998-01-13 City Of Hope RNA-DNA hybrid molecules of nucleic acid
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
US5432270A (en) * 1990-10-25 1995-07-11 Zasloff; Michael A. DNA encoding tracheal antimicrobial peptides
US5488035A (en) * 1991-12-06 1996-01-30 Pioneer Hi-Bred International, Inc. Peptide with inhibitory activity towards plant pathogenic fungi
CA2136103C (en) * 1992-05-26 2004-03-30 The General Hospital Corporation Antibiotic cryptdin peptides and methods of their use
US5422424A (en) * 1992-05-26 1995-06-06 The Regents Of The University Of California Antibiotic cryptdin peptides and methods of their use
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US5464823A (en) * 1993-07-20 1995-11-07 The Regents Of The University Of California Mammalian antibiotic peptides
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
EP0677061B1 (en) * 1993-10-14 1999-03-03 Seikagaku Corporation Polypeptides and anti-hiv agents prepared therefrom
US5635594A (en) * 1994-03-11 1997-06-03 University Of California, Los Angeles Gallinacins - antibiotic peptides

Similar Documents

Publication Publication Date Title
JP2000514806A5 (enExample)
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000506726A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000501324A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2001504437A5 (enExample)
JP2000502425A5 (enExample)
JP2000502485A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000502570A5 (enExample)
JP2000500912A5 (enExample)
JP2000501876A5 (enExample)
JP2000506195A5 (enExample)
JP2001503020A5 (enExample)
JP2001521681A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000510739A5 (enExample)
JP2000502316A5 (enExample)